ArticleJournal of cancer research and clinical oncology2023

A novel anti-CD47-targeted blockade promotes immune activation in human soft tissue sarcoma but does not potentiate anti-PD-1 blockade.

Andrej Ozaniak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.